Caitlin Tallant, MD | |
Uss Arlington (lpd 24), Fpo, AE 09564-1706 | |
(757) 567-1182 | |
Not Available |
Full Name | Caitlin Tallant |
---|---|
Gender | Female |
Speciality | Military Health Care Provider |
Location | Uss Arlington (lpd 24), Fpo, Armed Forces Europe |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992150692 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 0101263046 (Virginia) | Secondary |
171000000X | Military Health Care Provider | 0101263046 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Caitlin Tallant, MD Uss Arlington (lpd 24), Fpo, AE 09564-1706 Ph: (757) 567-1182 | Caitlin Tallant, MD Uss Arlington (lpd 24), Fpo, AE 09564-1706 Ph: (757) 567-1182 |
News Archive
House Research Institute (HRI) and Children's Hospital Los Angeles Children's Hospital) announced today final approval of grant funding by the National Institutes of Health (NIH) National Institute on Deafness and Communications Disorders (NIDCD) for a major five-year, FDA-approved clinical trial of the auditory brainstem implant (ABI) in children.
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and CellSeed Inc., a Japanese biotechnology firm, have entered into a two-year research agreement to study CellSeed's proprietary core technology in regenerative medicine, "Cell Sheet Engineering," LA BioMed President and CEO David I. Meyer, PhD, announced today.
Officials at Endocyte Inc., a cancer drug discovery and development company, announced Tuesday (Oct. 27, 2009) that the company has been awarded a patent from the U.S. Patent and Trademark Office covering vitamin receptor binding anti-cancer agents.
Currently, about 30 per cent of patients who receive oral surgery have their cancer recur. But a new, Canada-wide surgical trial using a new approach to remove tumours and pre-cancerous cells from the mouths of those diagnosed with early-stage oral cancer offers new hope for patients.
› Verified 4 days ago